PD-1 drugs for Breast Cancer

2 tracked PD-1 drugs in the Breast Cancer race. The class explanation lives on the PD-1 page; the full indication pipeline across every mechanism is on the Breast Cancer page.

2 approved / phase 4

Head-to-head evidence: Pembrolizumab vs Pembrolizumab berahyaluronidase alfa

The roster

← all PD-1 drugs